SaffermanAZKaneJMAronowitzJSGordonMFPollackSLiebermanJA. The use of clozapine in neurologic disorders. J Clin Psychiatry1994;55(suppl B):98–101.
2.
RogersDPShramkoJK. Therapeutic options in the treatment of clozapine-induced sialorrhea. Pharmacotherapy2000;20:1092–5.
3.
ZornSHJonesSBWardKMListonDR. Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol1994;269:R1–2.
4.
ReinsteinMJSirovskayaLAChasanovMAJonesLESangarapillaiM. Comparative efficacy and tolerability of benztropine and terazosin in the treatment of hypersalivation secondary to clozapine. Clin Drug Invest1999;17:97–102.
5.
BrownJHTaylorP. Muscarinic receptor agonists and antagonists. In: HardmanJGLimbirdLEMolinoffPBRuddonRWGilmanAG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996:149.